Skip to content
healthcare.dev

Restasis MultiDose

NDC 0023-5301, cyclosporine, emulsion, from Allergan, Inc..

Product NDC
0023-5301
Status
Listed
Labeler
Allergan, Inc.
Dosage form
EMULSION
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA050790
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0023-5301 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYCLOSPORINE.5 mg/mL

Pharmacologic classes

Calcineurin Inhibitor Immunosuppressant [EPC]; Calcineurin Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
0023-5301-05000235301051 BOTTLE in 1 CARTON (0023-5301-05) / 5.5 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7224d810-bb96-4682-a942-3355e6e8061a
  • NADAC price for package 00023530105

    GET /v1/drugs/nadac/00023530105

Use it

Look up 0023-5301 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0023-5301 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0023-5301. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.